Vitamin D and osteoporosis in chronic kidney disease
- PMID: 28940158
- PMCID: PMC5628182
- DOI: 10.1007/s40620-017-0430-x
Vitamin D and osteoporosis in chronic kidney disease
Abstract
Osteoporotic fractures are common in patients with chronic kidney disease (CKD). Morbidity and mortality are higher in CKD patients with a fracture than in the general population. The assessment of bone mineral density for fracture prediction may be useful at all CKD stages. It should be considered when this influences treatment decisions. Vitamin D deficiency is common in patients with CKD, particularly in patients with proteinuria, due to loss of 25-hydroxyvitamin D and its binding protein. Vitamin D supplementation should be prescribed early in the course of renal disease. For treatment and prevention of vitamin D deficiency in CKD patients cholecalciferol 800 IU/day or the equivalent per month is recommended just as in the general population.
Keywords: Bone mineral density; Chronic kidney disease; Osteoporosis; Vitamin D.
Conflict of interest statement
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Informed consent
For this review, informed consent from participants to clinical studies was not necessary. The review complies with the Helsinki code.
References
-
- Dey V, Farrah TE, Traynor JP, Spalding EM, Robertson SE, Geddes CC (2017) Symptomatic fracture risk in the renal replacement therapy population. Nephrol Dial Transplant 32(7):1211–1216 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
